Ibandronate [ibandronic acid] with or without capecitabine in elderly patients with early breast cancer

Trial Profile

Ibandronate [ibandronic acid] with or without capecitabine in elderly patients with early breast cancer

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Dec 2014

At a glance

  • Drugs Capecitabine; Ibandronic acid; Ibandronic acid
  • Indications Early breast cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms ICE
  • Most Recent Events

    • 13 Dec 2014 Results presented at the 37th Annual San Antonio Breast Cancer Symposium.
    • 16 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 11 Aug 2011 Planned End Date changed from 1 Oct 2010 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top